Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
The MHRA's Yellow Card reporting scheme continues to collect post-marketing data on such effects for all licensed medicines
The data shows tirzepatide has an edge at the highest doses, but both produce clinically meaningful weight loss far beyond what lifestyle alone typically achieves
You will regain you confidence
Abbreviations CVE: Cardiovascular event EHR: Electronic health record GLP-1RA: Glucagon-like peptide-1 receptor agonist MACE: Major adverse cardiovascular events NAFLD: Non-alcoholic fatty liver disease NASH: Non-alcoholic steatohepatitis PCI: Percutaneous coronary intervention PSM: Propensity score matching SGLT2: Sodiumglucose cotransporter 2 SMD: Standardised mean difference TG: Triacylglycerol References Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes
US$ 21.43
US$ 23.20
US$ 20.54
US$ 24.20
